MATEO ALAN bought TXG
June 4, 2026 · Form 4 insider transaction
MATEO ALAN bought 8,829 shares of 10x Genomics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
8,829
Price
$0.00
Total value
N/A
InsiderMATEO ALAN
RoleDirector
Company10x Genomics, Inc. (TXG)
SecurityClass A Common Stock
Transaction codeA: Grant or award
Transaction dateJune 4, 2026
Filing dateJune 8, 2026
Shares owned after85,877
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Constitute restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of Class A Common Stock upon vesting. 1/4th of the RSUs shall vest on each quarterly anniversary measured from May 21, 2026, subject to the Reporting Person continuing as a service provider through each such date.